RxDoctor Payments Data

James Oswalt, NP

Acute Care · Gahanna, OHNPI 1205550829

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,335in general payments, 2019–2025

Across 123 payments — averaging $35.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$962
  • Johnson & Johnson$318
  • Teleflex LLC$267
  • Pfizer$261
  • Endo Pharmaceuticals Inc.$252
  • Bayer$247
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$4,25098%
  • Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,335 in reported general payments places this provider in the 95th percentile of 1,101 acute care providers in Ohio.

See all acute care providers in Ohio

Medicare billing

Part B allowed, 2024
$72,983
Medicare patients
418
Services billed
2,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron28$20,298
Tamsulosin Hcl312$6,182
Finasteride115$2,094
Solifenacin Succinate16$1,187
Oxybutynin Chloride ErOxybutynin Chloride33$878
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst52$527
Cephalexin19$331
Alfuzosin Hcl ErAlfuzosin Hcl15$306
Oxybutynin Chloride18$283
Ciprofloxacin Hcl90$248
Cefdinir22$189
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim38$88

Paid to pharmacies, not to this prescriber.

Other acute care in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →